R-Pharm

R-Pharm company information, Employees & Contact Information

Explore related pages

Related company profiles:

R-Pharm – Russian high-tech pharmaceutical enterprise, successfully transformed from distribution to a fully vertically integrated specialty pharma player. ■Founded in 2001 in Moscow, fully private; ■Employs over 3500 highly qualified specialists, has 50+ branches at 9 countries; ■Products from a broad number of therapeutic areas in specialty/hospital care; ■RUR 74,1 B revenue in 2015. Key areas of R-Pharm’s competence include: manufacturing of finished drugs and APIs, R&D of innovative medicines and technologies, training and education for industry and health care specialists, venture investments in promising scientific data and research, cooperation with major international pharmaceutical companies and international universities in the field of drug development and combined clinical trials in Russia. Since foundation not less than 85% of profits reinvested into infrastructure and products development. R-Pharm group’s mission is to contribute to professional advancement of healthcare specialists, to bring affordable efficient pharmaceutical products to patients, ensure the product quality at each R&D and production level and encourage the innovative approach in healthcare problems solving.

Company Details

Employees
468
Founded
-
Address
Leninsky Prospect, 111, Moscow,central Federal District 119421,russian Federation
Phone
+7 (495) 956 79 37
Email
in****@****harm.ru
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Moscow, Central Federal District
Looking for a particular R-Pharm employee's phone or email?

R-Pharm Questions

News

Russian drugmaker R-Pharm searching buyers for its flagship factory in Germany - The Pharma Letter

Russian drugmaker R-Pharm searching buyers for its flagship factory in Germany The Pharma Letter

Russia’s R-Pharm heart drug added to Health Ministry guidelines for a rare condition - Новости GxP

Russia’s R-Pharm heart drug added to Health Ministry guidelines for a rare condition Новости GxP

Mitsui to Participate in the Russian Pharmaceutical Company R-Pharm | 2017 | Releases - mitsui.com

Mitsui to Participate in the Russian Pharmaceutical Company R-Pharm | 2017 | Releases mitsui.com

R-Pharm has registered Russia’s first generic drug for viral hepatitis C - Новости GxP

R-Pharm has registered Russia’s first generic drug for viral hepatitis C Новости GxP

The Azerbaijani pharmaceutical plant "R-PHARM" has signed an agreement with the Russian company Gerof - Baku.ws

The Azerbaijani pharmaceutical plant "R-PHARM" has signed an agreement with the Russian company Gerof Baku.ws

-Russia approves first COVID-19 prescription drug for sale in pharmacies - Reuters

-Russia approves first COVID-19 prescription drug for sale in pharmacies Reuters

R-Pharm group’s antitumor drug trial results are presented at an international conference in the USA - Новости GxP

R-Pharm group’s antitumor drug trial results are presented at an international conference in the USA Новости GxP

Russia’s R-Pharm eyes expansion in domestic market - The Pharma Letter

Russia’s R-Pharm eyes expansion in domestic market The Pharma Letter

R-Pharm’s drug receives orphan status in Saudi Arabia - Новости GxP

R-Pharm’s drug receives orphan status in Saudi Arabia Новости GxP

Russian drugmaker R-Pharm eyes buying Takeda plant in Yaroslavl - The Pharma Letter

Russian drugmaker R-Pharm eyes buying Takeda plant in Yaroslavl The Pharma Letter

R-Pharm has been authorized to conduct research on the Munjaro generic - Новости GxP

R-Pharm has been authorized to conduct research on the Munjaro generic Новости GxP

R-Pharm presents new data on olokizumab and goflicept at the APLAR Congress in Japan - Новости GxP

R-Pharm presents new data on olokizumab and goflicept at the APLAR Congress in Japan Новости GxP

AbbVie and R-Pharm win large state contract in Russia - The Pharma Letter

AbbVie and R-Pharm win large state contract in Russia The Pharma Letter

Clinical trials results of R-pharm’s drug on pediatric rheumatoid arthritis are published - Новости GxP

Clinical trials results of R-pharm’s drug on pediatric rheumatoid arthritis are published Новости GxP

R-Pharm presented new data on its drugs in Saudi Arabia - Новости GxP

R-Pharm presented new data on its drugs in Saudi Arabia Новости GxP

R-Pharm has begun clinical trials of a generic version of AbbVie’s Mavyret - Новости GxP

R-Pharm has begun clinical trials of a generic version of AbbVie’s Mavyret Новости GxP

R-Pharm reported phase III trial results of pembrolizumab - Новости GxP

R-Pharm reported phase III trial results of pembrolizumab Новости GxP

R-Pharm plant in St. Petersburg to be launched in 2025 - Новости GxP

R-Pharm plant in St. Petersburg to be launched in 2025 Новости GxP

R-Pharm has launched the new medication “Arcerix” for commercial distribution - Новости GxP

R-Pharm has launched the new medication “Arcerix” for commercial distribution Новости GxP

R-Pharm presented its original drug study data to an American audience - Новости GxP

R-Pharm presented its original drug study data to an American audience Новости GxP

R-Pharm will test its drug for Mediterranean fever in Turkey - Новости GxP

R-Pharm will test its drug for Mediterranean fever in Turkey Новости GxP

Illumina and R-Pharm receive device registration for sequencing platforms - Medical Device Network

Illumina and R-Pharm receive device registration for sequencing platforms Medical Device Network

R-Pharm has successfully registered the anti-tuberculosis drug Deltiba in Belarus - Новости GxP

R-Pharm has successfully registered the anti-tuberculosis drug Deltiba in Belarus Новости GxP

Russian enforcer closes two cases against R-Pharm - Global Competition Review

Russian enforcer closes two cases against R-Pharm Global Competition Review

Inside Mariupol: Russia’s new Potemkin village - Financial Times

Inside Mariupol: Russia’s new Potemkin village Financial Times

Goflikicept from R-Pharm has been registered in Russia - Новости GxP

Goflikicept from R-Pharm has been registered in Russia Новости GxP

The R-Pharm plant in Azerbaijan will start producing medicines in 2021 - Новости GxP

The R-Pharm plant in Azerbaijan will start producing medicines in 2021 Новости GxP

RDIF, The Gamaleya National Center, AstraZeneca and R-Pharm sign an agreement to cooperate on COVID-19 vaccine development - PR Newswire

RDIF, The Gamaleya National Center, AstraZeneca and R-Pharm sign an agreement to cooperate on COVID-19 vaccine development PR Newswire

R-Pharm finished the purchasing of the Yaroslavl Teva plant - Новости GxP

R-Pharm finished the purchasing of the Yaroslavl Teva plant Новости GxP

Russian manufacturer R-pharm comes to the rescue - Kuwait Times

Russian manufacturer R-pharm comes to the rescue Kuwait Times

Top R-Pharm Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant